JP2023523413A5 - - Google Patents

Info

Publication number
JP2023523413A5
JP2023523413A5 JP2022563869A JP2022563869A JP2023523413A5 JP 2023523413 A5 JP2023523413 A5 JP 2023523413A5 JP 2022563869 A JP2022563869 A JP 2022563869A JP 2022563869 A JP2022563869 A JP 2022563869A JP 2023523413 A5 JP2023523413 A5 JP 2023523413A5
Authority
JP
Japan
Prior art keywords
sequence
nucleic acid
epitope
coding nucleic
antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022563869A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023523413A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/028485 external-priority patent/WO2021216775A2/en
Publication of JP2023523413A publication Critical patent/JP2023523413A/ja
Publication of JP2023523413A5 publication Critical patent/JP2023523413A5/ja
Pending legal-status Critical Current

Links

JP2022563869A 2020-04-21 2021-04-21 抗原コードカセット Pending JP2023523413A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063013466P 2020-04-21 2020-04-21
US63/013,466 2020-04-21
PCT/US2021/028485 WO2021216775A2 (en) 2020-04-21 2021-04-21 Antigen-encoding cassettes

Publications (2)

Publication Number Publication Date
JP2023523413A JP2023523413A (ja) 2023-06-05
JP2023523413A5 true JP2023523413A5 (cg-RX-API-DMAC7.html) 2024-05-01

Family

ID=78269964

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022563869A Pending JP2023523413A (ja) 2020-04-21 2021-04-21 抗原コードカセット

Country Status (9)

Country Link
US (1) US20230310563A1 (cg-RX-API-DMAC7.html)
EP (1) EP4138890A4 (cg-RX-API-DMAC7.html)
JP (1) JP2023523413A (cg-RX-API-DMAC7.html)
KR (1) KR20230014694A (cg-RX-API-DMAC7.html)
CN (1) CN115803049A (cg-RX-API-DMAC7.html)
AU (1) AU2021258191A1 (cg-RX-API-DMAC7.html)
CA (1) CA3173905A1 (cg-RX-API-DMAC7.html)
IL (1) IL296854A (cg-RX-API-DMAC7.html)
WO (1) WO2021216775A2 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102945203B1 (ko) 2017-05-08 2026-03-31 시애틀 프로젝트 코포레이션 알파바이러스 신생항원 벡터
KR20210090650A (ko) 2018-11-07 2021-07-20 그릿스톤 바이오, 인코포레이티드 알파바이러스 신생항원 벡터 및 인터페론 억제제
SG11202113187WA (en) 2019-05-30 2021-12-30 Gritstone Bio Inc Modified adenoviruses
IL300026A (en) * 2020-08-06 2023-03-01 Gritstone Bio Inc Multiepitope vaccine cassettes
AU2024315334A1 (en) * 2023-07-28 2026-02-05 Lg Chem, Ltd. Conjugate for antigen delivery and use thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6514731B1 (en) * 1996-05-24 2003-02-04 Chiron Corporation Methods for the preparation of hepatitis C virus multiple copy epitope fusion antigens
AU2992600A (en) * 1999-02-11 2000-08-29 Genzyme Corporation Antigenic peptide concatomers
US20040037843A1 (en) * 1999-12-21 2004-02-26 John Fikes Inducing cellular immune responses to prostate cancer antigens using peptide and nucleic acid compositions
EP2385059A3 (en) * 2005-06-17 2012-02-15 Mannkind Corporation Methods and compositions to elicit multivalent immune responses against dominant and subdominant epitopes, expressed on cancer cells and tumor stroma
CN101721698B (zh) * 2008-10-24 2014-04-02 法罗斯疫苗公司 抗口蹄疫疫苗组合物及其制备和应用
WO2012114323A1 (en) * 2011-02-22 2012-08-30 Biondvax Pharmaceuticals Ltd. Multimeric multiepitope polypeptides in improved seasonal and pandemic influenza vaccines
WO2017152042A2 (en) * 2016-03-04 2017-09-08 New York University Virus vectors expressing multiple epitopes of tumor associated antigens for inducing antitumor immunity
TW202000907A (zh) * 2018-05-23 2020-01-01 美商葛利史東腫瘤科技公司 共有抗原
CN110003314B (zh) * 2019-04-11 2023-06-09 上海市计划生育科学研究所 H1n1流感病毒血凝素可诱发广谱保护性抗体的表位肽及其应用

Similar Documents

Publication Publication Date Title
JP2021525076A5 (cg-RX-API-DMAC7.html)
JP2022512912A5 (cg-RX-API-DMAC7.html)
JP2023526495A5 (cg-RX-API-DMAC7.html)
JP2023541108A5 (cg-RX-API-DMAC7.html)
JP2023521662A5 (cg-RX-API-DMAC7.html)
JP2022539417A5 (cg-RX-API-DMAC7.html)
JP2023523414A5 (cg-RX-API-DMAC7.html)
JP2022534282A5 (cg-RX-API-DMAC7.html)
Gardner et al. Infection of human dendritic cells by a sindbis virus replicon vector is determined by a single amino acid substitution in the E2 glycoprotein
JP2021524247A5 (cg-RX-API-DMAC7.html)
Maruggi et al. Self-amplifying mRNA-based vaccine technology and its mode of action
Johansson et al. Intradermal electroporation of naked replicon RNA elicits strong immune responses
ES2223051T3 (es) Vectores de adnc de alfavirus.
Anraku et al. Kunjin virus replicon vaccine vectors induce protective CD8+ T-cell immunity
McAllister et al. Recombinant yellow fever viruses are effective therapeutic vaccines for treatment of murine experimental solid tumors and pulmonary metastases
CN109415416A (zh) 用于诱导抗肿瘤免疫的表达肿瘤相关抗原的多表位的病毒介体
CN117157402A (zh) 顺式复制子构建体
JP2022512912A (ja) アルファウイルス新生抗原ベクター及びインターフェロン阻害因子
JP2023528300A5 (cg-RX-API-DMAC7.html)
AU3427100A (en) Stable recombinant influenza viruses free of helper viruses
JP2023509966A5 (cg-RX-API-DMAC7.html)
FI3652606T3 (fi) Jaettuihin tuumorineoantigeeneihin perustuva yleisrokote epästabiilien mikrosatelliitti (msi) -syöpien ennaltaehkäisyyn ja hoitoon
CN118086288B (zh) 多顺反子的自放大rna及制备方法
JP2004501646A5 (cg-RX-API-DMAC7.html)
WO2023227124A1 (zh) 一种构建mRNA体外转录模板的骨架